Analystreport

Aptose Biosciences Inc. (NASDAQ: APTO) had its price target lowered by analysts at Piper Sandler from $12.00 to $5.00. They now have an "overweight" rating on the stock.

Aptose Biosciences, Inc. - Common Shares  (APTO) 
Last aptose biosciences, inc. - common shares earnings: 3/10 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: aptose.com/investors